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Abstract—Deep brain stimulation (DBS) is an effective therapy as 
an alternative to pharmaceutical treatments for Parkinson’s disease 
(PD). Aside from factors such as instrumentation, treatment plans, 
and surgical protocols, the success of the procedure depends 
heavily on the accurate placement of the electrode within the 
optimal therapeutic targets while avoiding vital structures that can 
cause surgical complications and adverse neurologic effects. While 
specific surgical techniques for DBS can vary, interventional 
guidance with medical imaging has greatly contributed to the 
development, outcomes, and safety of the procedure. With rapid 
development in novel imaging techniques, computational methods, 
and surgical navigation software, as well as growing insights into 
the disease and mechanism of action of DBS, modern image 
guidance is expected to further enhance the capacity and efficacy of 
the procedure in treating PD. This article surveys the state-of-the-
art techniques in image-guided DBS surgery to treat PD, and 
discusses their benefits and drawbacks, as well as future directions 
on the topic. 
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I. INTRODUCTION 
FFECTING more than 10 million people worldwide, 
Parkinson’s disease (PD) is a chronic and progressive 
neurodegenerative disorder. Although it is still primarily 
characterized by related motor symptoms, including tremor, 
muscle rigidity and bradykinesia, the associated non-motor 
symptoms are being increasingly recognized. In addition to 
pharmacotherapy, deep brain stimulation (DBS) is a surgical 
treatment that can improve dopamine-related motor 
dysfunctions of the disorder, by implanting electrodes to 
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stimulate designated regions in the brain. Often, intra-
operative micro-electrode recording (MER) is performed to 
confirm or refine the therapeutic target determined in the pre-
surgical plan before the DBS lead is placed and secured in 
place. With the more commonly employed stimulation targets 
of the subthalamic nucleus (STN) and globus pallidus interna 
(GPi) to treat PD, the ventral intermediate nucleus (Vim) of 
the thalamus is an option for tremor-dominated PD.  
In DBS surgery, the electrode must be inserted through a bur-
hole to reach the optimal locus without damaging vital 
anatomy (e.g., blood vessels and ventricles) or stimulating 
other brain structures that can induce adverse responses [1]. 
The procedure has three main challenges. First, the DBS 
targets are often relatively small and poorly visualized using 
conventional medical imaging techniques for neurosurgical 
planning. Second, to avoid complications and unwanted 
outcomes, DBS lead insertion planning needs to consider 
various medical images that reveal different physiological 
information, which can be challenging and time-consuming 
for the surgeon to navigate. Finally, intra-operative tissue shift 
and post-operative DBS lead migration can occur, and intra-
operative refinement of stimulation target is often needed. 
Since the inception of DBS, image guidance has played 
important roles to tackle these issues from three major 
directions, including surgical targeting, navigation, and 
monitoring. In targeting, many specialized MRI techniques 
and computational methods have been developed to reveal the 
location and geometry of the surgical targets, especially for 
the STN, and more recently, to ensure optimal functional 
outcomes via incorporating functional and neural connectivity 
data. In general, based on the approaches used, the targeting 
methods can be grouped into structural and functional 
categories. The structural category can be further organized 
into indirect and direct methods. For surgical navigation, 
multiple neuronavigation software packages, with graphical 
rendering of surgical data, feature integrated image-processing 
algorithms, and automatic lead trajectory planning have been 
proposed to facilitate both pre-surgical planning and post-hoc 
outcome analysis. Lastly, for DBS monitoring, imaging and 
computational methods have been pursued to ensure correct 
electrode placement, as well as potentially monitoring 
functional responses to the stimulation and hemorrhage. 
Image-guidance in DBS surgery is a highly multi-faceted topic 
that involves image acquisition, image processing, 
computational models, and physiological modeling of the 
tissue and brain function. The advancement of DBS image 
guidance is imperative to ensure and possibly extend the DBS 
outcomes. while simultaneously offering needed insights 
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 regarding our brain circuitry and the true potential of DBS, as 
well as providing the knowledge for other therapies (e.g., 
focused-ultrasound surgery). This review primarily focuses on 
current methodological developments of image guidance for 
DBS to treat PD, in the three aforementioned aspects. Since 
more existing methods are devoted to surgical targeting, the 
review of this aspect is proportionally longer than the other 
two. A schematic of this review is shown in Fig. 1. 
 
 
Figure 1. Schematic of different components reviewed in image-
guidance for DBS surgery to treat Parkinson’s disease. 
II. STRUCTURAL INDIRECT TARGETING 
Indirect targeting approaches infer the centroid or geometry 
of the nucleus either from adjacent anatomical features, or by 
fitting an atlas to an individual’s anatomy as represented in 
pre-operative scans (e.g., T1w MRI) that fail to sufficiently 
visualize the target. This approach was used historically before 
the era of modern imaging, and to this day is still often used as 
a first approximation of the target location. 
A. Coordinate-based approaches 
Conventionally, the locations of the surgical targets are often 
inferred from their spatial coordinates in relation to more 
easily identifiable anatomical landmarks, as defined in well-
established atlases such as those from Talairach [2] or 
Schaltenbrand atlases [3]. Among different coordinate 
systems, the mid-point (i.e., middle commissure or MC) 
between the line connecting anterior commissure (AC) and 
posterior commissure (PC) (see Fig.2) is the most popular 
landmark to help locate the surgical targets, such as the STN. 
Efforts were therefore, made to improve the accuracy, 
consistency, and automation of AC and PC identification [4, 
5] through multi-template registration and local image feature 
learning as well as developing open standards for placing 
these features [6]. To adjust for individual variability, the 
coordinates are usually scaled by a factor that normalizes AC-
PC line lengths between the patient’s anatomy and the atlas 
employed, and some also use additional adjustments based on 
considerations, such as the third ventricle width [7], but there 
remains a lack of consensus among the specialists [8].  
B. Structural brain atlases and image registration 
Distinct from coordinate-based targeting that only offers 
points in 3D, full geometry and richer anatomical context can 
be obtained for the surgical target, by mapping structural brain 
atlases to the patient’s anatomy, using volume-to-volume 
image alignment. Besides the more recent digitized Talairach 
[2] or Schaltenbrand atlases [3], a number of brain atlases 
have been released to benefit DBS planning. As a starter, 
several subcortical atlases have been developed from 3D 
reconstruction of histological annotations [9-11], and were co-
registered to single-subject T1w MRI templates. For better 
anatomical representation, atlases averaged from a group of 
subjects have become a standard practice. In 2013, Haegelen 
et al. [12] built a PD-population-averaged atlas (named 
ParkMedAtlas) with manual segmentation of 7 pairs of 
subcortical structures. Xiao et al. [13, 14] constructed the MNI 
PD25 atlas with a novel T1-T2*-fusion contrast template and a 
co-registered histological atlas with 123 structure labels, and 
the ultrahigh-resolution BigBrain atlas [15, 16] (Fig.3a). More 
recently, Inglesias et al. [17] published a probabilistic atlas of 
the human thalamic nuclei with ex vivo MRI and histology of 
6 elderly subjects, and the new CIT168 atlas (Fig.3b&c) was 
created from 168 young healthy subjects by Pauli et al. [18]. 
Benefiting from enhanced tissue contrast of ultra-high field 7T 
MRI, Keuken et al. [19] and Wang et al. [20] proposed multi-
contrast averaged brain atlases with probabilistic maps of the 
basal ganglia structures using healthy subjects, which was 
applied prospectively in surgical cases [21]. Besides anatomy, 
atlases that include functional sub-divisions of target nuclei 
were also proposed, intended to better pin-point the 
therapeutic subregion. In this vein, Silva et al. [22] and 
Accolla et al. [23] provided parcellation for the GPi and STN, 
respectively. Based on the atlas of Chakravarty et al. [11], the 
DISTIL atlas [24] sub-divides the STN and GPi into 3 
different functional zones in the MNI152 template space.  
 
Figure 2. AC-PC lines and MC points defined in Talairach atlas 
space (Left) and Schaltenbrand atlas space (Right), shown in the 
mid-sagittal plane of the T1w ICBM152 template. Note that the 
differences in the definition of AC-PC, and thus the reference 
coordinates to locate surgical targets. 
Atlas-to-MRI registration strategies can impact the quality of 
targeting. In indirect targeting, such registration relies only on 
T1w MRI. Bardinet et al. [25] used the patient’s original and 
mirrored MRI to improve the atlas registration accuracy. Duay 
et al. [26] proposed an active-contour-based atlas registration 
for STN targeting. Using the Colin27 template [27] as a 
medium, Chakravarty et al. [28] employed pseudo-MR images 
 derived from digitized histological atlases to map the atlas to 
individual patients. Finally, different deformation models and 
publicly available registration software were assessed by 
Chakravarty et al. [29] and Ewert et al. [30], confirming the 
need for refined nonlinear warping.  
III. STRUCTURAL DIRECT TARGETING 
Direct targeting locates the surgical targets using MRI 
techniques and the associated image processing methods that 
can directly visualize them. Among these, 2D fast spin-echo 
(FSE) T2w MRI has the longest history in the clinic. 
However, such images are slow to acquire, making it difficult 
for the patients to tolerate. Often highly anisotropic resolution 
(3~5 mm axial slice thickness) images, or just a slab of the 
brain is obtained. Newer MRI sequences primarily aim to 
enhance the contrast of the nuclei, image quality (e.g., signal-
to-noise ratio and image resolution), or scanning efficiency. 
Full summaries of MRI sequences and nuclei segmentations 
are included in Tables S1 & S2 of the supplementary material. 
A. Inversion recovery imaging 
Inversion recovery (IR) imaging that reduces signals from 
designated tissues can boost the contrasts of subcortical 
structures. Ishimori et al. [31] proposed a 3D phase sensitive 
IR sequence with image contrast optimization to visualize the 
STN. Sudhyadhom et al. [32] proposed the Fast Gray matter 
Acquisition T1 Inversion Recovery (FGATIR) image to 
highlight the boundaries of subcortical structures and improve 
atlas fitting, demonstrating that FGATIR is superior to T2-
FLAIR in providing contrast between nuclei. Kitajima et al. 
[33] compared the FSE T2w and fast short inversion time IR 
(FSTIR) images, and concluded that it is easier to differentiate 
the STN from the adjacent SN in FSTIR images. Later, 
Nowacki et al. [34] evaluated the application of the modified 
driven equilibrium Fourier transform (MDEFT) sequence for 
depicting the GPi, though it was shown that magnetization 
transfer (MT) maps can better visualize the GP than MDEFT 
[35]. 
 
B. Susceptibility-weighted imaging 
Susceptibility-weighted imaging (SWI) enhances the contrast 
of the subcortical structures by taking advantage of their rich 
iron deposition. A typical SWI sequence produces a T2*w 
MRI, a phase image, and a magnitude-phase-fusion contrast. 
While the magnitude-phase-fusion image was originally 
intended for venography, the sequence has subsequently been 
customized to visualize the STN for DBS. Vertinsky et al. [36] 
optimized the scanning parameters of single-echo SWI images 
to best visualize the STN, and reported that the phase image is 
the best for the purpose. T2*w MRI exhibit high contrast for 
subcortical structures, but also exhibits evident susceptibility 
artifacts, which requires additional T1w MRI in surgical 
planning and may affect image registration quality. Xiao et al. 
[37] proposed a 10-echo FLASH sequence that produces 
different contrasts, including T1w and T2*w MRIs, whose 
image quality was enhanced through averaging adjacent 
echoes and optimizing scanning parameters. Alternatively, 
Volz et al. [38] attempted to recover the signal loss from 
susceptibility artifacts, by estimating pixel-wise signal loss 
and adaptively fusing multi-echo data. Finally, Wu et al. [39] 
proposed an inverse double-echo steady-state (iDESS) 
technique to depict the midbrain nuclei and reduce 
susceptibility signal loss.  
C. Quantitative imaging 
Quantitative MRI techniques can reveal the microstructural 
architectures of brain tissues by deriving their intrinsic MRI 
properties, including T1, T2, T2*, susceptibility, and 
magnetization transfer (MT) parameters. Therefore, these 
quantitative maps offer the opportunity to better describe the 
boundary between adjacent tissue types. Guo et al. [40] 
introduced the driven equilibrium single pulse observation of 
T1 and T2 (DESPOT1 and DESPOT2 [41], respectively) for 
DBS implantation. Helms et al. [35] proposed a novel, semi-
quantitative magnetization transfer (MT) imaging to improve 
contrast of basal ganglia structures, and discussed its 
feasibility in anatomical localization for DBS. Aside from the 
standard contrasts from the SWI sequence, T2* or R2* 
(1/T2*) maps [42] and later quantitative susceptibility maps 
(QSMs) [43] can also be derived to help improve the 
visualization of the STN and GP.  
 
 
Figure 3. (a) The STN and GPi rendered in 3D with other basal 
ganglia structures in the histological BigBrain atlas [15, 16]; (b) 
GPi is shown in axial view of the T1w CIT168 atlas [18]; (c) STN is 
shown in the coronal view of the T2w CIT168 atlas. 
D. Ultra-high field MR imaging 
Ultra-high field (>3T) MRI can boost the sensitivity, 
resolution, and signal-to-noise ratio of functional and 
anatomical images, and thus can offer more exquisite 
anatomical details. Abosch et al. [44] obtained T2w and SWI 
scans at 7T, and showcased the superior ability to effectively 
improve the identification of the GPi, STN, and Vim. Duchin 
et al. [45] found that T2w MRI at 7T has minimal distortion 
within the central part of the brain compared with at 1.5T, and 
thus is suitable for clinical use. Cho et al. [46] compared 
T2*w MRI at 1.5, 3, and 7T for visualizing the STN, while 
Deistung et al. [43] compared the contrast of subcortical 
structures in QSM, T2*w, phase, and R2* images at 7T, and 
 concluded that QSM demonstrates the highest  anatomical 
detail.  
E. Deep brain nuclei segmentation 
These aforementioned MRI techniques provide the 
opportunity for automatic nucleus segmentation to facilitate 
computer-assisted DBS planning and pathological studies of 
PD. Thus far, a number of groups have proposed and validated 
their methods, which can be categorized into atlas-based 
(single-atlas propagation and multi-atlas label fusion), model-
based, and deep learning-based methods. Distinct from atlas-
based segmentation in indirect targeting, the methods in this 
section involve image contrasts that display the nuclei of 
interest with sufficient contrast for registration or atlas 
selection. With a larger volume and visibility in T1w MRIs, 
segmentation of the GPi is more commonly reported. As for 
STN segmentation, Haegelen et al. [12] compared methods 
including single atlas propagation with different registration 
algorithms, ANIMAL [47] and SyN [48], and a non-local 
means label-fusion method [49] to segment subcortical regions 
using high-resolution sectional T2w FSE MRI at 3T. Their 
comparison offered the best results with a 0.64 Dice score 
using the ANIMAL algorithm. Also with 3T data, Xiao et al. 
[50] employed T2w pseudo-MRI to improve histological atlas 
registration to segment the STN. Later, to resolve the 
drawbacks of single-atlas propagation [51], the same group 
proposed label fusion segmentation methods for the midbrain 
nuclei, using fuzzy majority-voting on T2w MRI [51] and 
multi-contrast non-local means on SWI data [52], with the 
Dice score ranging 0.74~0.90 for their approaches. With 
respect to model-based approaches, Li et al. [53] used a band-
limited level set to segment the STN on 3T T2w MRI. At 7T, 
Visser et al. [54]  used both shape and multi-spectral intensity 
(QSM, T2w, T2*w, and fractional anisotropy map) modeling 
to segment the midbrain nuclei, while Kim et al. [55] used 
regression models to identify the STN in 1.5T T2w MRI based 
on a 7T training set. Most recently, deep learning has been 
employed to identify the STN [56], achieving a Dice 
coefficient of 0.90. Intending to serve a wider community, 
Manjon et al. [57] proposed pBrain, an online processing 
pipeline for segmenting the STN based on multi-atlas label-
fusion with multiple -scales and features in T2w MRI. 
IV. TARGETING WITH FUNCTIONAL DATA 
Distinct from the previous two categories that focus on 
providing the centroid or geometry for the anatomy to be 
stimulated, targeting with functional data is centered around 
the concept that targeting a specific functional region within 
the nucleus of interest may provide the maximum symptom 
improvements while minimizing adverse effects. Three 
general categories of functional targeting have been reported: 
probabilistic functional atlas mapping; connectivity-based 
targeting; and machine learning for surgical outcome. A 
summary of all currently available methods is available in 
Table S3 in the supplementary material. 
 
Among the various approaches, the probabilistic functional 
atlas mapping has the longest history. For this type of atlas, 
the locations of the active electrodes, the responses to 
stimulation, and the stimulator settings, are recorded for each 
individual patient. The stimulation locations of a cohort of 
patients with sufficient clinical benefits were deformed to a 
common anatomical atlas, while the influence of the applied 
electric field was modeled by a kernel function. Finally, the 
results were averaged to form a probabilistic representation of 
the “hot spot” to guide loci selection. As the earliest to 
develop such atlases, Nowinski et al. [58, 59] showed that 
DBS planning with their probabilistic functional atlas is better 
than solely relying on an anatomical atlases. Guo et al. [60] 
also presented a probabilistic atlas, built from intra-operative 
data of Finnis et al. [61], and demonstrated the advantage of 
the functional atlas in comparison to other anatomy-based 
approaches [40]. To further improve atlas-to-patient 
registration for stimulation target selection, D’Haese et al. [62, 
63] proposed a multi-template technique for their 
electrophysiological atlas, and reported < 1.75mm mean 
deviation from final implanted location when using the atlas 
for planning. From the same group, Pallavaram et al. [64] used 
spherical kernels instead of more commonly seen Gaussian 
kernels [60] to more accurately reflect the effect of electric 
stimulation.  
 
The second category of techniques utilize brain connectivity 
data, derived from diffusion and functional MRI to locate 
therapeutic neural pathways and sub-regions of nuclei that are 
difficult to visualize in structural MRI. Tractography obtained 
from diffusion MRI has been employed to determine optimal 
electrode placement within sub-regions of the STN [65, 66] 
and GPi [67]. Since the Vim nucleus of the thalamus is 
difficult to visualize on structural images, both tractography 
[68] and task-based functional MRI [69] have been used to 
help locate it. More specifically, Sammartino et al. [68] 
reported a mean discrepancy of 1.6mm between targeting 
using tractography and actual surgical choice. The extraction 
of dentatorubrothalamic (DRT) tract using tractography by 
obtaining tracts passing the dentate nucleus, thalamus, and 
motor cortex has been proposed as an alternative image-based 
target for tremor [70]. Compared with the first category of 
functional targeting that relies on the collection of previous 
target locations, connectivity-based targeting, often referred to 
as connectomic DBS, links the therapeutic benefits with 
activation of specific neural pathways.  
 
Lastly, the new data-driven approaches rely on machine 
learning to predict surgical outcomes at intended stimulation 
locations. Horn et al. [71] used brain connectivity data and 
linear regression models to calculate the surgical outcomes 
with an average 15% error margin for Unified Parkinson’s 
Disease Rating Scale (UPDRS) motor score improvements. 
Later, Baumgarten et al. [72] trained an artificial neural 
network model with 3D coordinates and levels of electric 
current to predict whether selected stimulation loci induce 
therapeutic benefits and side effects, obtaining the sensitivity 
of 93.07% and 73.47%, respectively. Similarly, Lin et al. [73] 
newly proposed a random forest classifier to differentiate 
ineffective vs. effective targets, but using instead a mean 
fractional anisotropy and tractography streamline fraction of 
the stimulation site within the STN to the rest of the brain. 
Their approach achieved a classification accuracy of 84.9%. 
 V. DBS NAVIGATION SOFTWARE & TRAJECTORY PLANNING 
Surgical navigation software provides the needed interface to 
visualize complex clinical information, pre-process imaging 
data, and possibly devise surgical plans, as well as perform 
post-hoc outcome analysis. Aside from commercial software, 
a number of DBS navigation software platforms have been 
developed for research purposes. The summary of the various 
current research-based navigation systems is listed in Table S4 
of the supplementary material. 
As the first of its kind, CranialVault [74] packaged automatic 
image processing tools, data visualization, and functional 
target selection [18] into one user interface. PyDBS [75] and 
IBIS NeuroNav [76] also offer surgical data visualization for 
planning DBS. With the first containing streamlined workflow 
to segment and register multi-modal scans, both of them 
incorporate efficient and automatic trajectory planning tools 
[77-80] as software plug-in extensions. Primarily to help 
analyze post-surgical impacts, PaCER [81] and DBSproc [82] 
were built to more accurately reconstruct the electrodes and 
offer tractographic analysis of surgical targets. On the similar 
note, LeadDBS [83] provides a platform to conduct statistical 
analysis for DBS procedures with integrated registration tools, 
an electrode reconstruction function, and integrated brain 
atlases, including both structural and connectomic types.  
A safe trajectory for DBS electrode insertion should consider 
multiple criteria, including but not limited to the distance to 
the optimal stimulation target while avoiding cerebral 
vasculature, ventricles, and structures, such as posterior limb 
of the internal capsule, that can induce adverse effects. 
However, proposing viable insertion paths by simultaneously 
considering all these conditions may impose a heavy cognitive 
demand for the surgeon, making the process arduous and time-
consuming. Therefore, several automated trajectory planning 
algorithms have been proposed by framing the task as 
optimizing cost functions that represent these criteria 
mathematically. 
 
Figure 3. Demonstration of the automatic DBS trajectory planning 
software proposed by Essert et al. [79, 80] in a case of STN 
stimulation (Courtesy of Dr. Caroline Essert, University of 
Strasbourg) 
While the earlier versions [84, 85] of these algorithms 
demonstrated the feasibility of such optimization frameworks 
with limited criteria, more recent approaches [77-80] 
incorporated a larger set of constraints, as well as introduced 
new data types into the optimization procedure. From the 
Montreal Neurological Institute group, Bériault et al. [77, 78] 
proposed automated DBS planning using SWI venography to 
ensure surgical safety and introduced a computational model 
for STN DBS stimulation with multiple active electrode 
contacts. In a similar vein, Essert et al. [80] emphasized the 
geometry of the insertion paths in their algorithm, and 
assessed the performance retrospectively. Later, Dergchyova 
et al. [79] further developed the Essert system, allowing the 
cost function to balance both the functional improvement 
predicted by probabilistic efficacy maps and the surgical risks. 
Despite various successes in automated trajectory planning 
algorithms, the strategy to weigh various path planning criteria 
is still largely determined by the users in a trial-and-error 
manner, and no systematic studies have been conducted to 
provide a unified framework to determine the optimal weights.  
VI. INTRA-OPERATIVE AND POST-OPERATIVE MONITORING 
Intra-operative monitoring can ensure the safety and quality of 
DBS, and the technical advancements have made it feasible to 
inspect many crucial factors during surgery, including 
electrode position, brain shift, intra-operative hemorrhage, and 
functional responses to stimulation. This is especially helpful 
for brain shift in DBS, which is able to impact surgical quality 
[86-88] in both intra-operative targeting and post-surgical 
electrode migration, with an averaged electrode shift of 1.41 
mm measured by Sillay et al. [86]. So far, besides more 
conventional and costly intra-operative MRI (iMRI) [89] and 
intra-operative CT (iCT) systems, transcranial sonography 
(TCS) [90, 91] and bio-mechanical modeling [87, 92] have 
also been reported. iCT is typically used to confirm the 
electrode position, and while it is an accurate equivalent to 
post-operative MRI measurement [88], it lacks soft tissue 
contrast. Besides electrode position verification, iMRI [89] 
can provide different image contrasts that visualize the 
surgical target, brain shift, and hemorrhage, and perform intra-
operative fMRI [93] to possibly refine electrode placement 
and stimulation parameters. A more cost effective modality, 
3D TCS was tested experimentally to guide DBS electrode 
placement [91]. With a limited accuracy of electrode tip 
localization [90] due to challenges in TCS-MRI fusion and 
image distortion, the method is not yet ready for clinical use. 
Lastly, finite element models (FEMs) [87, 92] have also been 
demonstrated in simulation [87] and clinical case study [92] to 
improve the electrode placement by accounting for brain shift, 
but further developments that allow efficient integration into 
the clinical workflow are needed. 
 
Post-operative imaging is another crucial step to verify final 
electrode position, particularly for potential electrode 
migration, assessment of surgical complications, and 
investigation of physiological impacts of the treatment. Recent 
studies [94, 95] with post-operative structural and functional 
MRI, have revealed the tissue and functional changes after 
DBS surgery. While CT avoids the need for meticulous 
estimation of heat dissipation with MRI in the presence of a 
DBS electrode, the physiological insights offered is limited. 
Studies [96] have recommended a specific absorption rate 
 (SAR) below 0.1 W/kg when planning post-operative MRI for 
DBS cases. 
VII. DISCUSSION 
A. Targeting: coordinates, anatomy, and function 
Atlas coordinate-based DBS targeting has a long history in the 
clinic. It assumes that the relative positions and sizes of DBS 
surgical targets, such as the STN, are consistent across 
subjects, and can tolerate minimum or lower quality imaging 
data. Meanwhile, non-negligible anatomical variability across 
subjects [51, 97, 98] has also been reported for the surgical 
target. The choice between the coordinate-based technique and 
direct targeting has been actively debated, largely for 
localizing the STN. While the earlier reports favored the first 
[99], more recent evidence [51, 98] prefer the latter. This 
discrepancy may likely be attributed to the improved image 
quality of MRI scanners, especially in terms of signal-to-noise 
ratio, image resolution, and newer scanning sequences, but 
unfortunately most studies [99] only reported results with 
fairly limited patients, or even healthy cohorts. Notably, the 
initial stimulation locations derived from coordinate-based 
methods and anatomical MRI are usually the estimated 
centroid or geometric center of the nucleus, which is often 
different from the therapeutic target. Inputs from functional 
information at the planning stage can therefore be important. 
Such insights can be made available through brain atlases that 
contain connectivity-based sub-divisions of the nucleus [24], 
probabilistic representation of effective stimulation loci [60, 
64], and group-averaged connectomes [71]. With 
physiological recording [100], we have observed that 
therapeutic regions are not necessarily bounded by the borders 
of a particular anatomy. To push this notion further, functional 
targeting with brain connectivity data, including diffusion and 
functional MRI, allows effective and tailored stimulation of 
nuclei subregions [101] or instead towards white matter 
pathways [70, 102] for targeted symptoms. 
 
Both indirect and direct targeting methods, and even many 
functional targeting approaches, have relied heavily on brain 
atlases, where significant progress has been made in adding 
super-high-resolution histological data [16], multi-contrast 
MRI [9, 13, 20, 64, 97], unbiased anatomical representation, 
and brain connectivity information [67, 71]. To accurately 
transfer the rich information from the atlases to an individual’s 
anatomy, suitable registration strategies are crucial. As 
anatomical variability in midbrain nuclei was revealed by 
high-quality structural MRI [51, 97], refined non-linear 
registration strategies [29, 30] are needed, and multi-contrast 
registration [16, 50, 71] is recommended for targets that are 
not visible on T1w MRI. Aside from brain atlas customization, 
concerns [103] have also been raised regarding potential 
insufficient representation of individual physiology when 
using group-averaged connectomic atlases for DBS planning. 
Comprehensive investigation is still required to confirm the 
impact of these approaches. 
  
Selecting the appropriate ground truth to assess DBS targeting 
methods is crucial and challenging. Typical references [99] to 
validate DBS planning techniques include final implantation 
locations shown in post-operative scans, intra-operative 
recording locations, coordinates shown in established atlases, 
structural MRI, and post-surgical symptom improvement. 
With possible tissue shift and electrode migration, stimulation 
targets determined during and after surgery may not overlap, 
and they may also exhibit an inherent bias away from the pre-
surgical plans. Although symptom improvement appears more 
meaningful as a ground truth, the possibility of alternative 
candidate targets with better outcomes make it difficult to 
assess prospective cases. Surprisingly, some functional 
targeting approaches [59, 69] used atlas coordinates as ground 
truth, which is not ideal, and the differences in validation 
metrics make it difficult to conduct cross-method  
comparisons. Finally, most reported planning techniques focus 
only on single contact stimulation. Multi-contact DBS 
planning, which is more complex to validate, is seldom 
mentioned in the literature. 
B. MR imaging and segmentation of surgical targets 
To date, a majority of the literature on novel structural MRI 
sequences for DBS is dedicated to the STN, for which, 
susceptibility-based contrasts [36, 37, 42, 44, 46], particularly 
7T QSM [43] showed superior results. Most MRI techniques 
surveyed in Table S1 were only developed based on small 
cohorts with primarily healthy subjects. This may affect their 
performance in PD patients, who can exhibit varied 
biochemical features in the brain and are less tolerant to 
relatively long scan sessions. In these novel sequences, typical 
slice thickness is still 2 mm, which is not ideal to accurately 
depict the geometry of the small STN, and is also in contrast 
to the finer isotropic resolutions used in automatic 
segmentations in Table S2. Unfortunately, none of these newer 
sequences has been reported in routine surgical practice in the 
literature. Another important factor of MR imaging for DBS is 
geometric distortion, which can originate from various 
sources, such as magnetic field inhomogeneity, chemical shift, 
and susceptibility differences. This factor was only assessed 
by Ishmori et al. [31] and Duchin et al. [45] in their studies, 
without disentangling individual contributing sources. With 
ultra-high field 7T MRI becoming more available, the inherent 
issues of image distortion from increasing field strength, 
particularly magnetic field inhomogeneity, will require 
rigorous examination [104]. 
 
Automatic segmentation algorithms for the STN have 
provided excellent results, achieving a Dice score of nearly 
0.90. Unlike other brain structures that can be easily visualized 
in standard T1w MRI, the technical developments for 
segmenting DBS targets, especially deep learning algorithms, 
were encumbered by limited quality MRI databases, the lack 
of the unified segmentation protocols, and effective MRI 
technique development. Yet, the existing techniques may not 
offer the same accuracy as reported on clinical scans, which 
often exhibit poorer rougher image quality. 
 
Although the benefits of connectomic DBS surgery are 
becoming increasingly evident, especially for targets that are 
difficult to depict solely by structural imaging, high quality 
diffusion and functional MRI face challenges in their 
integration into clinical routines. This makes development and 
 validation of relevant functional targeting algorithms with 
large clinical databases more challenging. 
C. Intra-operative and post-operative imaging in DBS 
Surgical target shift in DBS due intraoperative tissue shift has 
been measured to be more than 2mm in some cases [92, 105, 
106]. However, aside from surgical protocols that avoid CSF 
leakage to reduce this phenomenon, no effective algorithms 
similar to those in brain tumor resection [107] have been 
proposed based on inter-operative imaging for tissue shift 
correction. Intra-operative fMRI [93] offers the possibility of 
real-time monitoring for the impacts of DBS to improve the 
final targeting, but the high cost and special requirements for 
surgical setup make it difficult to access. Aside from 
confirming electrode position, post-operative MRI can also 
play a valuable role in advancing our understanding of the 
mechanism and true impacts of DBS [94, 95]. For both intra-
operative and post-operative imaging, image artifacts (e.g., 
streaking and distortion) induced from DBS leads can pose 
difficulty in obtaining accurate knowledge of final 
implantation location, and need to be carefully considered in 
imaging and outcome analysis. 
D. Future directions 
Studies [108] have indicated that instead of local circuitry 
modulation, DBS may exhibit widespread effects on the brain. 
Although still at the early stage, preliminary retrospective 
studies in connectomic DBS [70, 71, 73] have shown great 
potentials. The surgical strategy may eliminate or at least 
minimize the need for MER, potentially resulting in shorter 
operation time and improved patient comfort. The use of brain 
connectivity information in DBS planning and analysis will 
continue to enrich our understanding of the neural circuitry 
and the mechanism of DBS in the future.  
 
Current DBS strategy focuses primarily on dopamine-related 
motor symptoms of PD, and the non-motor issues (e.g., 
psychiatric symptoms and cognitive declines) are rarely 
considered. In addition, traditional stimulation targets, such as 
STN and GPi still have their limitations in therapeutic benefits 
and side effects [109]. These motivate the search for new DBS 
targets to treat PD, and a number of potential candidates, 
including individual nuclei and fiber pathways, have been 
proposed [70, 110], as well as multi-target stimulation to boost 
the impacts [111]. These demands pose two challenges on 
image-guidance of DBS. First, continued efforts are still 
needed to develop new MRI (structural and functional) 
techniques and the associated analysis methods to help 
identify the structures/pathways and confirm their impacts. 
Second, with richer image modalities required to improve 
DBS strategy, the challenges of multi-target stimulation, and 
new DBS devices, DBS navigation software will need to 
provide more intuitive and resource-efficient strategies for  
data visualization [112] and updated algorithms for improved 
electrode trajectory planning. 
 
Machine learning and deep learning techniques have shown 
early success in facilitating DBS planning in anatomical 
segmentation [53, 55-57], stimulation target selection [72, 73], 
and treatment outcome prediction [71]. While these techniques 
will continue to develop in the future to benefit the clinic, 
most of them have relied on limited research-grade MRI 
scans, whose resolution and image quality are superior to 
clinical images. Recent developments in deep-learning-based 
fast MRI [113], image denoising [114], and super resolution 
[115], along with hardware improvements, are expected to 
facilitate improved clinical data acquisition. Together with the 
open data initiatives that enable growing publicly available 
imaging repositories, learning-based methods may play a more 
important role in the future.  
 
The development of image-guidance techniques can also 
benefit other treatments for PD, such as focused ultrasound 
(FUS) [116]. In addition, it can also greatly contribute to 
asleep DBS surgery [117], where the electrode is implanted 
under general anesthesia, to improve the patient’s comfort. 
VIII. CONCLUSION 
This review provides the state of the art for medical image 
guidance in targeting, navigation, and monitoring of the DBS 
procedure to treat Parkinson’s disease. With an increasing 
demand for more enhanced and personalized treatments, 
future developments in DBS image guidance are expected to 
focus on incorporating connectomic data for improved 
functional targeting, updating imaging and neuronavigation 
techniques for new brain stimulation strategies (e.g., novel 
targets and multi-target stimulation), and finally, leveraging 
machine/deep learning to allow translation of the knowledge 
and tools developed in research for clinical data and 
workflows. Historically, image guidance in DBS has closely 
accompanied the birth and evolvement of this procedure, and 
will continue to contribute to its future development by 
providing in-depth insights of its mechanism and possibly 
extending its clinical benefits.  
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Table S1. Specialized MRI sequences for visualizing surgical targets of deep brain stimulation. 
	
	
Authors Field strength 
No. of 
subjects MRI sequence 
Anatomical 
structure  Resolution 
Imaging 
time Evaluation Conclusion 
Ishmori et al. 
(2007) 1.5T 
3 healthy & 
2 patients 
3D phase-
sensitive 
inversion 
recovery 
STN  1×1×2 mm3 16:56 min 
Less than 1% 
geometric distortion; 
Measured STN 
coordinates agree with 
the landmark-based 
approach 
The sequence offers 
distortion-free images for 
DBS targeting 
Kitajima et al. 
(2008) 3T 
4 healthy & 
20 patients FSTIR STN  0.39×0.625×2.5 mm
3 5:25 min 
Contrast ratio between 
STN and adjacent 
tissues: 0.10~0.23 
FSTIR is superior than T2w 
FSE in the STN targeting 
Sudhyadhom 
et al. (2009) 3T 3 patients FGATIR 
GPi, STN, 
Vim  0.8×0.8×1 mm
3 11:14 min 
CNRs of STN, GPi 
and Vim against 
surrounding tissues: 
5.96, 6.06 & 7.27 
FGATIR reveals richer 
anatomical features than 
conventional T1w and T2w 
MRI 
Vertinsky et al. 
(2009) 3T 8 healthy 
SWI phase map 
using SENSE  STN 0.55×0.75×1.5 mm
3 < 2:30 min 
Best visual scores 
based on 3 raters with 
TE=20ms and 
SENSE=1.40 
Delineation of the STN was 
superior in phase images  
Volz et al. 
(2009) 3T 
4 healthy & 
4 patients 
T2*w multi-echo 
FLASH  STN  1×1×2 mm
3 3:30 min Mean CNR of STN vs. WM: 37.1 
Combining multi-echo 
information can reduce 
susceptibility artifacts and 
improves the STN contrast 
Abosch et al. 
(2010) 7T 6 healthy SWI 
GPi, STN & 
Vim  0.95×0.95×0.95 mm
3 15:00 min 
Qualitative visual 
comparison promotes 
SWI over T2w MRI 
in subcortical 
structure visualization 
MRI at 7 T have yielded 
improved anatomic 
resolution of deep brain 
structures 
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Cho et al. 
(2010) 7T 
11 healthy 
& 1 patient 2D GRE (T2*w) STN, GPi  0.25×0.25×2 mm
3 5:54 min 
Mean normalized 
intensity difference of 
STN vs. SN: ~0.20; 
only visual 
assessments for GPi 
7T MRI images showed 
marked improvements in 
visualization STN and GPi 
than 3T 
Y. Xiao et al. 
(2012) 3T 
4 healthy & 
2 patients 
Multi-contrast 
Multi-echo 
FLASH sequence 
(R2* & SWI) 
STN  0.95×0.95×0.95 mm3 7:05 min 
Contrast ratio between 
STN and SN: 0.31 
(R2*map) 0.36 
(T2*w)  
Improved scan efficiency 
(multiple contrasts in one 
shot) and STN contrast 
with lower image distortion  
Duchin et al. 
(2012) 7T 12 patients TSE STN 0.39×0.39×2 mm
3  5:30 min No contrast assessments  
7 T MRI has comparable 
distortion in central region 
to 1.5T MRI, and can be 
used for DBS surgery 
Deistung et al. 
(2013) 7T 9 healthy 
Multi-orientation 
GRE (QSM) 
STN, GPi & 
Vim 0.4×0.4×0.4 mm
3 16:57 min Visual assessments for nuclei contrasts 
High resolution QSM offers 
superb contrast for 
subcortical structures for 
the STN, GPi & Vim 
Nowacki et al. 
(2015) 3T 13 patients MDEFT GPi   1×1×1 mm
3 12:00 min 
MDEFT-based 
targeting offers 
1.07mm error from 
the actual lead 
position 
Direct targeting of GPi 
based on MDEFT is 
accurate and reliable. 
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Table S2. Automatic segmentation algorithms for subthalamic nucleus (STN). 
	
	
 
Authors Field strength  No. of Subjects 
Image 
contrasts Resolution Algorithm Dice score 
Xiao et al.  
(2012) 3T 
3 healthy & 3 
patients T2w & T2*w  0.95×0.95×0.95 mm
3 Multi-contrast label propagation  L: 0.63±0.06; R: 0.61±0.06 
Haegelen, et al. 
(2013)  3T 10 patients T1w  1×1×1 mm
3 label propagation (ANIMAL registration) 
L: 0.641±0.004; 
R: 0.640±0.006 
Haegelen, et al. 
(2013)  3T 10 patients T1w  1×1×1 mm
3 label propagation (SyN registration) L: 0.626±0.003; R: 0.640±0.006 
Haegelen, et al. 
(2013)  3T 
10 patients (leave-
one-out) T2w  1×1×1 mm
3 Nonlocal means patched-based label fusion 
L: 0.631±0.005; 
R: 0.575±0.022 
Xiao et al.  
(2014) 3T 
10 patients (leave-
one-out) T2w  1×1×1 mm
3 Fuzzy label-fusion method  L: 0.74±0.08; R: 0.77±0.05 
Xiao et al.  
(2015) 3T 
10 patients (leave-
one-out) T2*w & phase  0.95×0.95×0.95 mm
3 Multi-contrast nonlocal means label-fusion method  
L: 0.877±0.026; 
R: 0.900±0.048 
Kim et al.  
(2015) 1.5T & 7T 
26 patients (16 
training & 10 
testing) 
T1w & T2w Not provided Feature-based shape prediction to transfer knowledge from 7T to 1.5T 
L: 0.624±0.002; 
R: 0.659±0.011 
Visser et al. 
(2016) 3T & 7T 53 healthy 
T1w, T2w, 
T2*w, QSM, 
FA 
 0.5×0.5×0.5 mm3 Multi-contrast intensity-based generative model ~0.8 
Park et al.  
(2019) 3T 
102 patients (data 
augmentation added, 
80 for training) 
T2*w  0.375×0.375×0.375 mm3 Deep convolutional neural network 0.902 
Manjon et al. 
(2020) 3T 
15 healthy (leave-
two-out) T2w  0.5×0.5×0.5 mm
3 Multi-atlas patch-based label fusion with multi-scales and multi-features 
L:0.856;  
R: 0.855 
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Table S3. Survey of functional targeting methods for deep brain stimulation in treating Parkinson’s disease (sMRI=structural MRI, 
DWI=diffusion-weighted imaging, fMRI= functional MRI). 
	
Author & 
Year Target Method No. of subjects Data modality Reference space Outcomes Ground truth 
Guo et al. 
(2005) STN 
Construct a functional atlas that 
contain electrophysiological data 
131 patients for 
atlas construction 
& 8 patients for 
testing 
sMRI, 
physiological 
recording 
CJH-27 atlas 
2.84 mm (Absolute 
differences between the 
centroids of the segmented 
STN and the real targets) 
 Real target location 
D'Haese et al. 
(2005) STN 
Automatic selection of DBS 
target points using multiple 
electrophysiological atlases  
14 patients 
sMRI and 
electrophysiologica
l recording 
Schaltenbrand-
Wharen atlas 
Mean deviation from final 
implant: 1.66 mm (Left) and 
1.74 mm (right) 
final implantation 
position in post-op CT 
Nowinski et al. 
(2007) STN 
Construct a probabilistic 
functional atlas that represents 
spatial frequency of best contacts 
184 patients 
sMRI, 
Physiological 
recordings 
AC-PC based 
cartesian space 
The "hot" functional STN 
resides inside anatomical STN 
Coordinates in 
Schltenbrand-Wahren 
atlas 
Sammartino et 
al. (2016) Vim 
Tractography-based 
methodology for the stereotactic 
targeting of the ventral 
intermediate nucleus 
14 patients and 
15 healthy 
subjects 
DWI subject native space 
Euclidean distance between 
tractography-based and 
surgical target was 1.6+/-
1.1mm 
Intra-operative 
stimulation & 
landmark-based 
targeting 
Pallavaram et 
al. (2008) STN 
A probabilistic efficacy map was 
constructed with a spherical shell 
kernel 
19 patients (95 
stimulation data) 
T1w MRI, and 
clinical 
assessments 
In-house atlas 
space 
Final stimulation locations are 
within the "hot zones" of the 
efficacy map 
final implantation 
position in post-op CT 
Anderson et al. 
(2011) Vim 
 A finger movement task is used 
to trigger activation in relevant 
regions 
58 healthy 
subjects fMRI MNI space 
Within 3 mm of clinically 
optimized targets 
Optimized targets 
based on anatomical 
landmarks 
Horn et al. 
(2017) STN 
Linear regression based on 
functional and structural 
connectomic patterns is used to 
predict motor symptom 
improvements 
51 patients for 
training and 44 
patients for 
testing 
fMRI & DWI MNI space An average error of 15% UPDRS improvement 
Post-surgical UPDRS 
motor scores 
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Akam et al. 
(2017) STN 
Voxel-based statistical analysis 
was used to identify significant 
treatment clusters, which was 
mapped to relevant cortical 
regions 
20 patients T1w MRI & DWI MNI space 
The maximum overall efficacy 
is X=-10(-9.5) mm, Y=-13(-1) 
mm and Z=-7(-3) mm in 
MNI(AC-PC) space. 
functional outcomes 
before and 1-yr after 
surgery 
Baumgarten et 
al. (2018) STN 
An artificial neural network is 
trained based on stimulation loci 
coordinates and electric current 
to predict therapeutic benefits 
and side effects 
30 patients (130 
tested electrode 
positions)  
T1w MRI and 
clinical 
assessments 
ParkMedAtlas 
atlas 
The mean sensitivity and 
specificity were 93.07% and 
69.24% for the therapeutic 
effect, 73.47% and 91.82% for 
the side effect 
Therapeutic and side 
effects (no effect, 
partial effect, or full 
effect) 3 months 
before and after 
surgery 
Middlebrooks 
et al. (2018) GPi 
10 segments of GPi is derived 
from structural connectivity to 
10 cortical and subcortical 
structures; activation of each 
segment is correlated with motor 
symptom improvements 
11 patients T1w MRI & DWI Subject native space 
GPi segments related to 
primary and supplementary 
motor areas are strongly 
corrected with UPDRSIII 
improvement 
UPDRSIII scores from 
preoperative and 6-
month follow-up visits 
Coenen et al, 
(2020) DRT 
DRT was tracked and used as a 
direct thalamic or subthalamic 
target 
36 patients T1w & T2w MRI, DWI 
Subject native 
space 
Close distance to the DRT is 
correlated with tremor 
reduction 
Surgical outcomes 
Lin et al.  
(2020) STN 
Random forest classifier based 
on mean FA and streamline 
fraction 
58 patients for 
training, 19 for 
testing 
T1w & T2w MRI, 
DWI 
Subject native 
space 
84.9% accuracy to 
discriminate ineffective 
targets 
Surgical outcomes 
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Table S4. Public surgical navigation software for deep brain stimulation (sMRI=structural MRI, DWI=diffusion-weighted imaging). 
 
	
	
	
	
	
	
	
Name Platform Imaging modality 
Trajectory 
planning 
Electrode 
reconstruction targeting technique Preinstalled atlas 
CranialVault 
(D'Haese et al., 
2012) 
CRAVE CT & sMRI Yes Yes Based on probabilistic functional atlas 
In-house 
electrophysiological 
and subcortical 
atlases 
PyDBS 
(D’Albis et al., 
2015) 
3D Slicer sMRI yes No Based on structural atlas 
In-house population-averaged 3T MRI atlases 
(T1w & sectional T2w) of PD patients 
DBSproc 
(Lauro et al., 2016) AFNI 
sMRI, DWI & 
CT No Yes 
Patient-specific direct 
targeting N/A 
IBIS 
(Drouin et al., 
2017) 
IBIS 
neuronav 
sMRI, 
angiography, 
CT 
Yes No Based on structural atlas N/A 
Lead-DBS 
(Horn et al., 2018) MATLAB 
sMRI, 
tracrography No Yes 
Based on structural 
and connectomic 
atlases 
17 cortical & 18 subcortical public atlases and 
averaged brain connectomic atlas 
PaCER 
(Husch et al., 2018) MATLAB sMRI & CT No Yes NA N/A 
